Four years ago, some of Gerd Zettlmeissl’s friends thought he was crazy to leave his top job at vaccine giant Chiron to work for an Austrian spin-out company a tenth Chiron's size...
The Liverpool School of Tropical Medicine, UK, has received $50.7 million from the Gates Foundation for research on treatments for infectious and tropical diseases such as malaria
Cambridge Antibody Technology Group Plc, which is traded on both the LSE and Nasdaq markets, said an agreement was struck at the 11th hour over a royalty dispute with Abbott Laboratories Inc.
Sigma-Aldrich, a US-based Nasdaq-listed life science company, has agreed to license a gene delivery technology from Oxford BioMedica and will pay $5 million for a stake in the spin out from Oxford University.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.